Trial intelligence / Profile preview

Ultrasonographic Monitoring of Infliximab in RA

NCT01282528Phase 4Unknown

Sponsor
Peking Union Medical College Hospital
Start
Sep 2010
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

infliximab
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01282528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01282528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call